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Background: Limited decision-making capacity (DMC) of older people affects their abilities to communicate about
their preferences regarding end-of-life care. In an advance directive (AD) people can write down preferences for
(non)treatment or appoint a proxy as a representative in (non)treatment choices in case of limited DMC.
The aim is to study limited DMC during the end of life and compare the background, (satisfaction with) care and
communication characteristics of people with and without limited DMC. Furthermore, the aim is to describe patient
proxies’ opinions about experiences with the use of (appointed proxy) ADs.
Methods: Using a questionnaire, data were collected from proxies of participants of a representative sample of the
Longitudinal Aging Study Amsterdam (n=168) and a purposive sample of the Advance Directive cohort study
(n=184). Differences between groups (with and without limited DMC, and/or with and without AD) were tested
with chi-square tests, using a level of significance of p < 0.05.
Results: At a month before death 27% of people had limited DMC; this increased to 67% of people having limited
DMC in the last week of life. The care received was in accordance with the patient’s preferences for the majority of
older people, although less often for people who had limited DMC for more than a week. The majority of the
proxies were satisfied with the communication between physician and the patient and them, regardless of DMC of
the patient. Of people with an AD, a small majority of relatives indicated that the AD had been of additional value.
Finally, no differences were found in the role of the relative and the satisfaction with this role between people with
and without a proxy AD.
Conclusions: Although relatives have positive experiences with ADs, our study does not provide strong evidence that
(proxy) ADs are very influential in the last phase of life. They can best be seen as a tool for advance care planning.
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Older people are frequently affected by multiple progres-
sive illnesses, many of which arise during the last year of
life [1]. In the course of these illnesses older people may
lose the capacity to accept or reject medical treatments.
Limited decision-making capacity (DMC) can occur in
degrees and last for a longer or shorter time period and
can have various causes, e.g. due to a progression of* Correspondence: eol@vumc.nl
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reproduction in any medium, provided the ordementia, reduced consciousness or (sub)comatose state
due to a physical illness. Limitations in DMC of older
people affect their abilities to communicate about their
care preferences in end-of-life decisions. Decision-
making capacity has been divided into five dimensions:
understanding the facts involved in the decision, appre-
ciation of the nature and importance of the decision,
understanding the benefits and risks of the decision,
communication about the decision, and deliberation
based on personal values [2,3].
As patients’ quality of life is a primary focus in end-of-
life care it is important that others are familiar with their
preferences when they become unable to express thoseLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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situation by discussing their preferences with both health
care professionals and proxies (advance care planning). A
comparison between patients with usual care plus advance
care planning and patients with only usual care showed
that advance care planning improved end-of-life care and
patient and family satisfaction [4]. People may write down
their preferences in an advance directive (AD), a written
statement in which they can specify preferences in end-of-
life care and treatment decisions. An AD becomes of rele-
vance when a person loses his or her capacity to make
decisions. An AD can either make statements about re-
ceiving or refusing treatments in certain situations or a
statement in which the person can appoint a health care
proxy who will represent the individual when he or she
has limited DMC. In the Netherlands, ADs that concern
refusal of treatment are legally binding.
Previous studies on DMC at the end of life have pre-
dominantly explored the terminology, how to assess
DMC, hypothetical situations of limited DMC, DMC
and end-of-life decisions and DMC in specific sub-
groups such as cancer or dementia patients [2,3,5-9].
Yet, little is known about the number of older people
experiencing limitations in DMC in the general popula-
tion, and how it affects end-of-life care, communication
and use of ADs.
Therefore, we aim to explore how many older people
develop limited DMC and how long before death these
older people develop limited DMC. Second, we aim to
describe the potential differences in background charac-
teristics, the patient’s satisfaction with communication
about care (according to their relative), and relatives’ sat-
isfaction with communication about care between older
people with full DMC until death and older people with
limited DMC. In this, we also explore whether this is dif-
ferent for people who have limited DMC for a longer or
shorter period before death. Third, we want to describe
the experiences with use of ADs for people who had an
AD and limited DMC for shorter or longer period before
death, according to their relatives. Finally, we study
whether the relatives of people with and without an
appointed proxy AD differed in terms of the satisfaction
with the role of the proxy in the decision-making
process.
Methods
Study design and sample
Our sample consisted of deceased participants of two
cohort studies. A representative sample of the Longitu-
dinal Aging Study Amsterdam (LASA), and a purposive
sample of the advance directive cohort study (ADC).
The cohort members died between 2006–2009. As
LASA is a cohort of older people, and the youngest
deceased participant of the LASA cohort was 57, weselected deceased ADC participants from aged 57 years
and over (omitting 9 younger members). Data about the
last three months of life of the deceased people were
collected using written questionnaires that were sent to
a close relative. For the deceased sample members we
checked who had given permission to contact a named
relative after their death; in both cohorts this was asked
when starting the cohort. If this permission was given,
we sent a letter to the relative to ask whether they were
willing to participate in the study via an answering card.
The data collection took place in 2009–2010. The Med-
ical Ethical Committee of the VU University Medical
Center approved the study design. The samples included
all deaths, including sudden deaths.
LASA sample members
LASA is based on a nationally representative sample of
older adults aged 55–85 years, stratified by age and gen-
der and drawn from three regions in the Netherlands.
These regions reflect the national distribution of urban-
isation and population density. In 1992–1993 the LASA
sample was recruited and a total of 3107 subjects were
enrolled. Data collection takes place every three years.
An additional cohort was recruited from the sampling
frame exactly ten years after the first cycle of the cohort
(n=1002 enrolled in 2002–2003). The sampling, data-
collection and response rates of the LASA have been
described more extensively elsewhere [10]. There were
311 participants in the LASA cohort who had died be-
tween 2006–2009 and had previously given permission to
contact a proxy. Of them, 284 proxies were approached,
as 27 proxies could not be found. A total of 168 proxies
completed the questionnaire (59%), 69 proxies (25%) did
not respond, and 47 proxies (17%) did not want to partici-
pate. The proxies of the deceased LASA members were
predominantly a child of the deceased member (83%), fol-
lowed by the partner (7%), another family member (5%),
and non-relative (e.g. a friend) (5%).
ADC sample members
In the Netherlands, two associations provide the most
common types of ADs ‘Right to Die-NL’ (NVVE in Dutch)
and Dutch Patient Association (NPV in Dutch). The
NVVE provides four types of standard Ads: 1. a refusal-of-
treatment document (ROTD) states in what situations a
person does not want to receive life-prolonging treatment;
2. a do-not-resuscitate order (DNR); 3. a document in
which somebody can appoint a health care proxy (proxy
AD); and 4. An advance euthanasia directive (AED) in
which a person can state in which situations he or she
would wish life to be ended. As with oral euthanasia
requests, it does not have to be granted by the physician
and a physician is only allowed to grant when the criteria
for due care are met. The NPV is a Christian oriented
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in which a person declares that he or she prefers to receive
proper care, meaning no excessive, medically useless treat-
ments at the end of life. In addition, it states that the per-
son in question does not want active ending of life.
The advance directive cohort is based on a sample of
5561 people who have requested an AD from the Right
to Die-NL (NVVE), and 1261 people who have formu-
lated an AD through the Christian Dutch Patient Associ-
ation (NPV). The first measurement was in 2005 with
follow-ups every one and a half years. The entire design
of the ADC study is described more extensively else-
where [11]. Of the ADC participants, 263 died between
2006–2009 and had given permission to contact a proxy.
Of them, 256 proxies were approached (NVVE n=232,
NPV n=24), as 7 proxies could not be reached (NVVE
n=6, NPV n=1). A total of 184 (NVVE n=167, NPV
n=17) proxies completed the questionnaire (72%), 52
proxies (20%) did not respond, and 20 proxies (8%) were
not willing to participate. The proxies of the deceased
ADC members were a child of the deceased member
(53%), followed by the partner (39%), and another family
member (6%), and a non-relative (2%). The relationship
between respondent and deceased differed significantly
between the LASA and ADC cohort.
Measures
All data were derived from the questionnaires the prox-
ies of deceased LASA and ADC members had filled in.
The proxies completed a questionnaire that consisted of
structured questions including age, gender, DMC, pos-
session of an AD, received care, contact about and satis-
faction with care, communication about and influence of
ADs on care, the role of the proxy in decision-making,
and cause and place of death. Decision-making capacity
was asked by the question ‘Until what moment was the
deceased sample member capable of making end-of-life
decisions’, with the response categories ‘until the mo-
ment of death, minutes before death, hours before death,
days before death, a week before death, several weeks be-
fore death, a month before death, or more than a month
before death’. The proxies were asked if the deceased sam-
ple member had formulated an AD (answered by yes, no,
or do not know), and if so, which AD was formulated
(one or more answers could be ticked in response categor-
ies appointed health care proxy, advance euthanasia dir-
ective, refusal of treatment document, do-not-resuscitate
order, will-to-live statement). The questions about contact
and satisfaction (concerning care (aim 2), the use of ADs
(aim 3 and 4), role of the proxy (aim 4)) were distin-
guished in two types of questions: the proxies were asked
to provide their perceived view of the decedents’ contact
and satisfaction as well as the proxies’ own contact and
satisfaction with the person’s care. With regard to the carebeing according to patient preferences, the proxies were
asked to assess if the care received by the person was in
accordance with the preferences of the person (yes, partly,
no, unknown).
Analyses
For describing the period of limited DMC of Dutch
older people (aim 1 and 2), we used the deceased LASA
sample members, since this sample is representative for
the Netherlands. We included 165 of the 168 cases for
which the question on limited DMC was filled in by the
proxy. For describing background characteristics of
deceased LASA sample members we recoded the vari-
able on DMC in three categories: full DMC until death
included ‘until a the moment of death’ and ‘minutes be-
fore death’; limited DMC before death a week or less be-
fore death, included ‘hours before death’, ‘days before
death’ and ‘a week before death’; and limited DMC more
than a week before death included ‘several weeks before
death’, ‘a month before death’, and ‘more than a month
before death’. We selected these categories as during
preliminary analyses a shift of limited DMC was found
especially during the last week of life (see also Figure 1).
Differences between groups were tested with chi-square
tests, using a level of significance of p < 0.05.
For the study aims that focused on (proxy) ADs, we
used the cases from the LASA cohort and in addition
we included people from the ADC cohort. Purpose for
this was to have a larger number of people with a
(proxy) AD. For describing experiences with ADs (aim
3), we selected people with an AD who had limited
DMC before death (n=120). In the analyses we com-
pared people with limited DMC for a week or less before
death with people who had limited DMC more than a
week before death. For studying the influence of a proxy
AD (aim 4) we selected all people with limited DMC be-
fore death (n=213) and compared the group with a
proxy AD with the group without a proxy AD. Differ-
ences between groups were tested with chi-square tests,
using a level of significance of p < 0.05.
Results
Limited DMC
Figure 1 displays the period of limited DMC before
death in the LASA sample. While 27% of the people
experienced limited DMC more than a month before
death, this percentage especially increased up to 67%
during the last week of life. Only 24% remained lucid
until shortly before death.
DMC and patient and care characteristics
Older people with full DMC, limited DMC for a week or
less, or limited DMC for more than a week before death
did not differ in age, gender, and having an AD (Table 1).
Figure 1 Period of limited decision-making capacity before death (LASA-sample, rounded percentages, n=165).
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an AD, of which only 3% of people with full DMC and
1% of people with limited DMC had formulated an
appointed proxy AD.
For people with limited DMC a week or less before
death, the limitation in DMC was mostly due to being
unconscious or comatose state (52%). In people with
limited DMC more than a week before death, dementia
was the most common cause of limited DMC (59%).
People who had full DMC until death were more often
diagnosed with a heart disease than people with limited
DMC (32% versus 12%). The two groups of people with
limited DMC significantly differed in diagnosis: for
people with limited DMC a week or less before death
the diagnosis was more often cancer (28% versus 13%)
and less often old age (13% versus 36%) or dementia (0%
versus 21%) than for people with limited DMC more
than a week. While there was no difference between
hospitalization in the last month of life between people
with full DMC and limited DMC overall (full DMC 37%,
limited DMC 36%), people with limited DMC for more
than a week were hospitalized in the last week of life less
often than people with limited DMC a week or less be-
fore death (22% versus 49%).
People with full DMC mostly died in their own home:
in 45% of cases compared to 26% of people with limited
DMC dying at home. The two groups of people with
limited DMC significantly differed in place of death:
people with limited DMC a week or less before death
more often died in hospital (41% versus 13%) and less
often in a nursing home (6% versus 52%) than people
with limited DMC for more than a week before death.
DMC and (satisfaction with) communication about care
As shown in Table 2, according to the relatives of the
deceased, in more than half of the cases, care receivedwas in general in accordance with the patient’s prefer-
ences both for people with full and people with limited
DMC (both 71%). Looking within the group of people
within limited DMC, people with limited DMC for more
than a week significantly less often received care accord-
ing to their preferences (60%) than people with limited
DMC for a week (81%).
While in all groups the physician most frequently
communicated treatment choices to patient and relative
(between 49% and 65%), they most frequently discussed
this only with the relative in people with limited DMC
for a week or more (31%). Relatives, when asked about
their own experiences, were in large majority satisfied
with contact between physician and patient, and be-
tween him or herself and the physician; no significant
differences between the different groups were found.
The percentage of relatives being (very) unsatisfied ran-
ged from 5% to 11%.
DMC and the role of ADs in communication
For people with limited DMC and with an AD (Table 3),
the majority of the physicians were aware of the AD
(83% and 87%) and the content of the AD (fully aware
82% and 76%), according to their relatives. However, the
two groups of different periods of limited DMC differed
significantly concerning the time at which the physician
had been informed about the patient having an AD: for
people with limited DMC more than a week before
death the physician had more often been informed be-
fore the illness (83% versus 52%) than people with lim-
ited DMC for a week or less. The relatives of people
with limited DMC during the last week of life reported
more often that the physician had not discussed the AD
during the last week of life than relatives of patients with
limited DMC for a week or more (41% versus 21%).
Relatives of people with limited DMC a week or less
Table 1 Patient and care characteristics and decision-making capacity (LASA-sample, n=165, rounded percentages)*
Full DMC Limited DMC before death
total more than a week before death a week or less before death
n=39 (%) n=126 (%) n=56 (%) n=70 (%)
Reason of incompetence† n.a
Unconscious/coma‡ 32 8 52
Dazed 32 23 40
Demented‡ 27 59 0
Confused 19 26 12
Symptom burden 4 4 6
Not able/willing to think of end of life 4 4 5
Communication difficult 1 2 0
Stroke 1 2 0
Other 3 6 2
Age
<70 15 14 7 19
70-85 51 43 43 43
>85 33 44 50 39
Male 59 47 43 50
Cause of death‡ ¶
Cancer 16 25 13 28
Old age 11 23 36 13
Heart disease 32 12 13 12
Stroke 11 10 2 16
Lung disease (asthma/CARA/COPD) 8 10 4 15
Dementia 0 10 21 0
Other 22 11 13 10
Advance Directive (AD) 17 17 15 19
Type of AD †
Advance euthanasia directive 6 8 11 6
Do-not-resuscitate order 6 6 2 8
Appointed proxy 3 1 2 0
Refusal of treatment document 3 3 2 3
Will-to-live statement 3 2 0 3
Type of care during the last 3 months of life
District nurse 39 45 39 49
Informal home care 53 36 27 43
Formal home care 36 34 25 42
Nursing home care ¶ 3 29 7 15
Volunteer help 10 9 13 6
Main attending physician in last three months‡ ¶
General practitioner 86 59 45 70
Specialist elderly care 3 29 7 17
Medical specialist 11 13 48 13
Hospitalization in last month of life ‡ 37 36 22 49
Place of death‡ ¶
Hospital 28 28 13 41
Own home 45 26 23 28
Nursing home 8 27 52 6
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Table 1 Patient and care characteristics and decision-making capacity (LASA-sample, n=165, rounded percentages)*
(Continued)
Residential home 17 15 11 22
Hospice 3 3 2 3
*Missing observations were less than 5% of the total n, except for the group ‘full DMC until death’, between 1 and 9 missing observations.
†More than one answer could be given.
‡Difference between the groups ‘limited DMC more than a week before death’ and ‘limited DMC a week or less before death’ significant (p<0.05).
¶Difference between groups ‘full DMC until death’ and ‘limited DMC before death significant’ significant (p<0.05).
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communication with physicians was ‘good’ (63% versus
48%), compared to the relatives of people with limited
DMC more than a week before death. In both groups
over half of the relatives considered the AD to be of add-
itional value (54% and 65%). In both groups about one
third of relatives thought the ADs had not had influence
of care, mostly because the AD did not relate that the
patient’s situation (15% and 17%), but also because the
physician did not want to cooperate (11% and 2%).Table 2 Communication of physician with older people and t









Don’t know 18 14
Physician communicated understandably concerning treatment choices
Yes, to patient and relative 56 58
Yes, only to patient 6 5
Yes, only to relative 0 20
No 19 9
Don’t know 19 8
Patient satisfaction with contact between physician and patient†
(Very) satisfied 71 67
Neutral 18 14
(Very) unsatisfied 0 2
Don’t know 12 18
Satisfaction of relative with contact between physician and patient
(Very) satisfied 79 75
Neutral 12 18
(Very) unsatisfied 9 7
Satisfaction of relative with his/her contact with physician
(Very) satisfied 81 73
Neutral 10 18
(Very) unsatisfied 10 9
*Missing observations were less than 5% of the total n, except for the group ‘full DM
†Difference between the groups ‘limited DMC more than a week before death’ and
‡Difference between groups ‘full DMC until death’ and ‘limited DMC before death sProxy and having an appointed proxy AD
According to the relatives, approximately two-thirds of
the people with and without an appointed proxy AD
(Table 4), in general received care in accordance with
the patient’s preferences (both 67%). However, for a
small percentage of people without a proxy AD it was
not known whether care was in accordance with the
patient’s preferences (11%, with AD 0%). No significant
differences were found between both groups concerning
being satisfied with the influence of patient and proxy inheir relatives and decision-making capacity before death
Limited DMC before death























C until death’, between 1 and 9 missing observations.
‘limited DMC a week or less before death’ significant (p < 0.05).
ignificant’ significant (p < 0.05).
Table 3 Experiences with the use of ADs of older people
who had and AD and with limited decision-making
capacity before death (n = 120, rounded percentages)*
Older people with an
AD who had limited
decision-making
capacity more than a
week before death
Older people with an
AD who had limited
decision-making





was aware of the
existence of the AD(s)
Yes 83 87
No 6 2
Don’t know 11 11
Responsible physician
was aware of the
content of the AD(s)
Yes, fully 82 76




about the AD(s) ‡
Before illness 83 52
During illness 13 47




in the last week of
life with physician‡
Yes, with patient 38 32
Yes, with proxy 33 17
No 21 41
Don’t know 8 10
Relative’s perspective
on communication
process about AD(s) ‡
Good 48 63
Not good, not bad 12 11
Bad 32 11
No communication 8 10













Table 3 Experiences with the use of ADs of older people
who had and AD and with limited decision-making








AD had no influence,
because:
31 35
- did not relate to
patient’s situation
15 17




- the AD was signed
too long ago
4 7
*Missings in all groups of all variables were less than 5% of the total N; 101
respondents of ADC sample and 19 respondents of LASA sample.
‡Difference between the two groups significant (p < 0.05).
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with and without proxy AD reported to be (very)
satisfied.
Discussion
While about a quarter of older people has limited DMC
for more than a month before death, there is especially
an increase in limited DMC in the last week of life. In
the last week two thirds of older people have limited
DMC; about a quarter remains lucid until death. Limited
DMC a week or less before death is mostly due to
reduced consciousness or coma, while limited DMC
more than a week before death is predominantly due to
dementia. People who had full DMC until death died
significantly more often of a heart disease than people
with limited DMC before death. The care received was
in accordance with the decedent’s preferences for the
majority of older people although less often for people
who had limited DMC for more than a week. The ma-
jority of the relatives were satisfied with the communica-
tion between physician and the patient and them,
regardless of DMC of the patient. Of older people with
limited DMC and an AD, relatives described the com-
munication process about ADs more frequently as good
for patients with limited DMC for a week or less than
for patients with limited DMC for more than a week. A
small majority of relatives indicated that the AD had
been of additional value. Finally, no differences were
found in the role of the relative and the satisfaction with
this role between people with and without a proxy AD.
Strengths and limitations
A strength of our study is the combination of two
cohorts with different strengths. The LASA cohort is
representative for the Dutch older population allowing
Table 4 Role of the relative in decision-making for older
people with limited decision-making capacity before
death and with or without an appointed proxy AD
(n=213, rounded percentages)
Older people without an
appointed proxy AD





























Not influential 12 12
No decisions
had to be made
20 12
Satisfaction of relative




Not satisfied 7 14
Satisfaction of relative




Not satisfied 5 13
*Missings in all groups of all variables were less than 5% of the total N; people
without an appointed proxy AD: 54 respondents of ADC sample and 109
respondents of LASA sample; people with a proxy AD: 49 respondents of ADC
sample and 1 respondents of LASA sample.
†Difference between the two groups significant (p <0. 05).
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quency and circumstances of limited DMC in the last
phase of life of older people. Since ADs do not fre-
quently occur in the Dutch older population, the ADC
cohort allowed us to study ADs in relation tocommunication about care in people with limited DMC.
A limitation of this study is that DMC was examined
with a single question. Also, the sample was constituted
of all deaths, including sudden death without an end-of-
life phase and decision-process. However, these deaths
especially occurred in the group with full DMC. That
data were collected through proxies of died people
brings two types of bias. First is potential recall bias due
to the retrospective reporting: the cohort members
deceased between half a year and three and a half years
before the proxies entered the study [12]. However, it is
likely that proxies remember circumstances around the
death of a relative. Second, it is known that proxies are
not always accurate in assessing the patient’s own views.
Yet, literature indicates that proxies are more likely to
give accurate information when it concerns more factual
information such as care characteristics of a deceased
relative, while less factual information is more likely to
be assessed less accurate by proxies [12,13]. Of course,
the experiences of the relatives themselves concern an
important focus of this study, and for that part the prox-
ies are the most suitable respondents Finally, a limitation
of the study is that reports about overall satisfaction of
patients in care can be limited and optimistic, although
it has been found that asking about satisfaction on spe-
cific aspects of care (e.g. contact) can be more meaning-
ful [14].
DMC and background characteristics
DMC may not be limited during a large part of an illness
trajectory, yet, towards the end of life a considerable
number of people develop limited DMC, especially dur-
ing the last week before death. People usually associate
limited DMC with dementia. However, limited DMC can
also develop in people with chronic physical illnesses [9].
We did find that the reason of limited DMC is related to
the length of limited DMC, with people with illnesses
related to old age such as dementia generally having lim-
ited DMC than people with other chronic diseases such
as cancer. These findings are in line with the chronic ill-
ness trajectories described by Murray et al. [15]. Of
course, people can also die suddenly, e.g. through a heart
attack or fatal stroke; thus without an illness trajectory
[16]. This group is generally lucid until death.
DMC and (satisfaction with) communication about care
The time period of limited DMC can affect continuing
communication in end-of-life decision-making [2,9].
However, our findings showed that all groups of patients
and their relatives were in majority satisfied with their
contact with the physician. It has been reported that in-
formation giving by a physician is the most important
factor in care satisfaction for older people [17]. Even
though people had limited DMC, the physician in many
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patients themselves, and although people had full DMC,
the physician frequently also communicated treatment
choices with relatives. These findings underline that phy-
sicians generally approach both patient and relatives
during the decision-making process. This is probably
related to the fact that the decline in patients’ DMC is a
process in which it is difficult to demarcate the moment
that DMC becomes limited [2]. It might also be related
to the physicians recognizing that it might be beneficial
to include both patients and relatives in discussing care
as the needs of the family may exceed those of the pa-
tient [18]. A timely start with advanced care planning by
the physician and patient with full DMC is recom-
mended to encompass diverse perceptions of autonomy
and DMC [8] and advocate for the patient’s quality of
life [19]. Of course in this one has to realize that people
may theoretically have full DMC and the mental abilities
to discuss treatment, while they may emotionally not be
ready to accept the course of their illness and choose
what treatment options to pursue in a particular situ-
ation [9,20]. This is in line with our finding of a small
group of older people who had limited DMC because
they were not able or willing to think of the end of life.
DMC and the role of ADs
While in general a majority of relatives, thus also a large
group of relatives of older people without AD, indicated
care being according to the patient preferences and
being satisfied with the communication with the phys-
ician, the relatives of persons with an AD have positive
experiences with the use of the AD. In older people with
limited DMC for more than a week the AD was dis-
cussed with the patient or relative in the last week of life
of the patient in three quarter of cases; in older people
with limited DMC in the last week or less this was done
in about half of the cases. Over half of the relatives con-
sidered the AD of additional value, while at the same
time only a small group considered that the AD deter-
mined decisions. This might indicate that relatives also
see the role of an AD more as an aid in communication
on end-of-life care and treatment, as some authors have
suggested [21,22]. However, it would be desirable for fu-
ture research to get more in-depth insight in the ways in
which relatives experience the additional value of ADs.
It is remarkable that the satisfaction with the decision-
making process of people with and without an appointed
proxy AD was similar, as reported by relatives. This may
be influenced by the fact that when patients develop lim-
ited DMC, physicians generally discuss treatment
choices with relatives, a result supported by the results
of a previous study [23]. Therefore, it seems that an
appointed proxy AD is not necessarily needed to experi-
ence a satisfying decision-making process in whichrelatives are involved. However, the beneficial value of
this AD might be the increasing of awareness of prefer-
ences of older people. Among relatives of older people
without an appointed proxy AD, it was for a small per-
centage of people not known if care was in accordance
with preferences of the deceased.
Conclusions
In conclusion, a considerable number of people devel-
oped limited DMC, especially during the last week of life
a. Although people may fear becoming limited in DMC,
our study suggests that becoming limited in DMC does
not affect satisfaction of relatives in care at the end of
life. Our study does not provide strong evidence that
(proxy) ADs have much influence in the last phase of
life. However, relatives of people with an AD in majority
had positive experience with the use of the AD in the
last phase of life. It can probably best be seen as a tool
that can be useful in advance care planning.
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